台股 » 個股 » 昇陽 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

昇陽

(3266)
可現股當沖
  • 股價
    24.35
  • 漲跌
    ▼0.50
  • 漲幅
    -2.01%
  • 成交量
    996
  • 產業
    上市 營建類股
  • 34人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
昇陽 (3266)籌碼相關-永豐金-苓雅 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

永豐金-苓雅 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/05/2000.00224.3024.85-21,367-0.15%
2024/05/10524.4700.0024.0051,2820.39%
2024/05/09324.63324.8224.2001,2550.00%
2024/05/081024.801025.0524.4001,2370.00%
2024/05/0700.001824.9425.45-181,209-1.49%
2024/05/061024.901425.3225.90-41,150-0.35%
2024/05/031426.0500.0025.60141,0801.30%
2024/05/02723.9228.124.1724.85-21.1922-2.28%
2024/04/301923.3100.0022.60198362.27%
2024/04/26620.2500.0020.9566160.97%
2024/04/2400.00120.2520.10-1579-0.17%
2024/04/0800.00219.6519.90-2507-0.39%
2024/03/1800.000.717.2017.55-0.7566-0.13%
2024/03/120.718.88118.6518.40-0.3751-0.03%
2024/03/11119.9000.0019.8517080.14%
2024/03/04520.65120.6520.5046720.59%
2024/02/2300.00119.3019.35-1721-0.14%
2024/02/22219.7300.0019.5027870.25%
2024/02/1900.00120.6520.25-1820-0.12%
2024/02/1600.00419.6519.75-4803-0.50%
2024/02/05118.2500.0018.2017870.13%
2024/01/31118.6000.0018.5517900.13%
2024/01/25118.2500.0018.2517820.13%
2024/01/1900.00117.7018.10-1776-0.13%
2024/01/18818.25817.9517.9507730.00%
2024/01/0800.00219.8519.80-2706-0.28%
2024/01/04119.2000.0019.1016900.14%
2024/01/03119.6000.0019.6516840.15%
2024/01/02119.85119.9519.8506770.00%
2023/12/21118.9000.0018.6516380.16%
2023/12/19119.0000.0019.3016220.16%
2023/12/150.119.500.819.5019.60-0.7597-0.12%
2023/12/131.419.5800.0019.351.45610.25%
2023/12/122.219.86220.8019.800.25230.04%
2023/12/114.221.1000.0021.154.24201.00%
2023/12/0500.00317.3017.40-3296-1.01%
2023/11/22117.3000.0017.1512190.46%
2023/07/17314.3500.0014.3531951.54%
2023/05/1200.000.112.7012.45-0.1142-0.08%
2023/05/110.112.3000.0012.500.11390.08%
2023/04/2100.00112.8512.80-1134-0.75%
2023/03/0100.00212.1012.15-265-3.03%
2022/10/2400.00110.9010.80-1200-0.50%
2022/10/07110.9000.0010.9012120.47%
2022/06/3000.00112.4512.50-1815-0.12%
2022/05/20213.85213.9014.0507680.00%
2022/05/12112.6000.0012.5517360.14%
2022/05/09113.2500.0013.2517200.14%
2022/04/25113.9000.0013.9016630.15%
2022/04/1900.005014.6514.70-50613-8.14%
2022/04/186014.871016.3014.85505908.46%
2022/04/1500.00216.4516.45-2541-0.37%
2022/04/131216.49916.5016.5034560.66%
2022/04/121215.581316.2816.65-1341-0.29%
2022/04/11115.1000.0015.1511830.54%
2021/03/1600.00713.6513.75-7143-4.89%
2021/03/11213.7500.0013.7021441.39%
2021/01/08515.82115.5015.6541542.60%
2021/01/07115.3500.0015.8011660.60%
2020/11/231014.651014.6014.6001070.00%
2020/09/1100.00113.7513.75-1103-0.97%
2020/07/2300.001013.4013.40-10226-4.41%
2020/05/151014.0300.0014.15102673.73%
2020/03/2000.00111.8011.70-1134-0.75%
2019/10/0700.00515.1515.45-5362-1.38%
2019/09/27514.0500.0014.2053471.44%
2019/09/1800.00214.7014.30-2334-0.60%
2019/09/1700.00314.6014.55-3332-0.90%
2019/09/16514.5200.0014.4553271.53%
2019/09/05114.10114.0013.9003140.00%
2019/07/3000.00212.0512.05-2118-1.69%
2019/07/08211.7000.0011.7021011.98%
2018/09/0400.00513.4013.00-5333-1.50%
2018/09/03512.8500.0012.8552611.91%
2018/07/1800.00111.5011.75-1196-0.51%
2018/06/2200.00213.0012.30-2135-1.47%
2018/06/21111.7000.0011.851691.43%
昇陽半攻先進製程、先進封裝 明年營運勝今年Anue鉅亨-2023/12/24
昇陽半生技布局報捷 多合一液態蛋白檢測平台完成臨床前測試Anue鉅亨-2023/12/21
昇陽 相關文章